Cite
HARVARD Citation
Williams, J. et al. (2016). Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet gastroenterology and hepatology. pp. 15-24. [Online].